Acute Lymphoblastic Leukemia and Nutritional Influences Essay

Exclusively available on Available only on IvyPanda® Made by Human No AI

Description of the Disease, Its Prevalence, and Incidence

Acute lymphoblastic leukemia (ALL) is an uncommon type of cancer that attacks blood’s white cells in the bone marrow. The disease begins with immature cells and progresses rapidly, so the keyword acute is included in the label. Terwilliger and Abdul-Hay (2017) hypothesize that this illness is caused by aberrant lymphoid cell growth and division on a global scale. Therefore, it can manifest itself in more severe symptoms such as convulsions, nausea, and headaches. While there is no definitive explanation for why mutations occur, known risk factors include smoking, being overweight, a compromised immune system, and past rounds of chemotherapy. Terwilliger and Abdul-Hay (2017) estimate that the prevalence of ALL in the United States is 1.6 per 100,000 population. According to the study, in 2016, medical practitioners diagnosed 6590 incidences of the illness and identified 1400 fatalities (Terwilliger & Abdul-Hay, 2017).

Discussion of Possible Laboratory Testing

Laboratory testing is a critical aspect in determining whether a clinician can appropriately assess a client’s condition. A medical professional may order a series of assessments to diagnose acute lymphoblastic leukemia, comprising blood, bone marrow, and imaging techniques. A complete blood count is used to determine the precise number of each blood cell type in an individual, whereas a peripheral blood smear is used to determine alteration in the appearance and mobility of blood cells. By examining a bone marrow specimen for symptoms of leukemia, bone marrow testing can assist the health care team in progressing with the diagnosis.

Chromosomal Analysis

Chromosome analysis, also known as karyotyping, is recommended in the treatment ALL. The key reason for its requirement is that it enables physicians to discover chromosomal abnormalities. Both comprehensive information and investigation of these anomalies are required for ALL diagnoses. No test processing is required before the operation, typically conducted only if a pregnancy diagnostic test fails or if symptoms are consistent with a condition caused by a chromosomal disorder. According to the American Cancer Society (2018), ALL is caused by chromosomal abnormalities, the most frequent of which is the Philadelphia chromosome. Additionally, ALL may be caused by chromosome translocations such as abnormalities between chromosomes 4 and 11, 8 and 14, and deletions and rearrangements.

Disorder Origin: Considerations for Practice and Patient Education

To gain a complete understanding of ALL, it is necessary to examine its probable etiologies. Jimenez-Morales et al. (2017) observe a Mendelian heritability in select ALL cases. Additionally, this form of cancer should be considered multifunctional, implying a complicated genetic architecture. The architecture where mutations in low-penetrance genes take part in DNA repair, xenobiotic sensitivity, immune system, and regulatory genes contribute to disease progression (Jimenez-Morales et al., 2017). Therefore, this is the disorder’s root, and it is critical to research its origins, comorbidities, manifestations, treatment options, and prognoses extensively. Concerning practical considerations, the key attention should be on the reality that ALL mostly affects children. Thus, physicians must maintain continual touch with family members regarding any healthcare choices. After analyzing a health history and doing comprehensive interviews with guardians, a clinician can raise alarms about the likelihood of gene abnormalities causing ALL.

Gene Mutation of the Disease

Certain individuals get a specific kind of cancer due to DNA alterations inherited from their guardians, significantly increasing their risk of becoming ill. However, this is not a common occurrence in acute lymphoblastic leukemia. Hereditary abnormalities are a problem only in individuals with pre-existing genetic disorders indicated as potentially acquiring ALL. However, biologists now realize that the condition arises from repeated genetic alterations that impair preceding B- and T-cell development while accelerating cell growth. As a result, cancerous, immature lymphoid cells cluster in the bone marrow and peripheral circulation.

How Genetics Can Influence Policy Issues

Genetics has developed into one of the most intriguing and forward-thinking fields of medical research. Nevertheless, for biologists to extend the frontiers of what is understood and search for the genetic link of illnesses, large amounts of information must be collected and analyzed. This information is critical for researchers to investigate the incidence and extent of genetic risk factors, estimate the death rates associated with genetically linked illnesses, and analyze the usefulness of genetic screening techniques (Wright Glayton et al., 2019). As a result, numerous legislative difficulties arise, most notably due to public sensitivity to genetic education and healthcare information protection. Although certain standards are in place to ensure the greatest transparency conceivable in genetic monitoring and experimentation, they contain numerous loopholes (Wright Glayton et al., 2019). As a result, several authorities have prioritized resolving growing concerns and further restricting the administration’s and private enterprises’ accessibility to personal health information.

Nutritional Influences for the Cause of Acute Lymphoblastic Leukemia

ALL is caused by genetic alterations in an individual’s bone marrow cells. As a result, oncogenes are activated in the DNA of the bone marrow cell when a person is diagnosed with ALL, while tumor suppressor genes are silenced. While nutritional effects are not separate, specific considerations must be made. Slayton et al. (2020) speculate that prenatal toxic compounds and radiation may play a role in ALL. As a result, if a mother consumes foods polluted with high radioactive contamination or harmful chemicals during pregnancy, her child is more likely to acquire genetic abnormalities such as those that cause ALL.

The Process of Nutritional Assessment as It Relates to Health, Prevention, Screening, Diagnostics, Prognostics, etc.

Malnutrition is a significant problem for pediatric patients since it affects the patient’s care and its usefulness. Additionally, a well-balanced change in diet is an incredibly effective tool for alleviating clinical manifestations and eliminating the adverse effects of prescription medications. A nutritional examination and particular dietary recommendations can help reduce the likelihood of newborns developing genetic abnormalities in pregnant women. Healthy examinations are critical for people living with cancer, as they are at a higher risk of malnutrition. The anthropometric and dietary tests can provide adequate information for the care professional to establish a nutritional intrusion tailored to the individual’s present health condition, diagnosis, and long-term outlook.

Ethical Considerations of Acute Lymphoblastic Leukemia (ALL)

A medical ethics organization seeks to clarify ethical difficulties that arise throughout patient care. Individual ethicists and representatives of ethics committees should have training in various fields, including moral judgment, medical ethics, health legislation and regulation, and interpersonal interactions (Miladinia et al., 2017). This ethical imperative requires ALL patients’ needs to take precedence above the caretakers’, clinicians’, and societal concerns, responsibilities, and expectations (Miladinia et al., 2017). Acknowledging the ethical environment concerning leukemia medication will better equip practitioners with quality standards for navigating ethical problems and enhancing patient care.

How Genetics Can Improve Care and Health Outcomes while Reducing Cost to usual Practices

Over the last few years, much attention has been paid to the promise of genetic medicine, with predictions that genomes will soon drive the detection, identification, and management of human diseases. However, this transformation has been considerably slower, even in areas where the data is frequently compelling, such as pharmacogenomics. There are several reasons for this, including the demand for economic assets and the necessity for the will to overcome impediments inhibiting healthcare reform.

When things get complicated or costly, using a gradual approach may be the best course of action. Individualizing treatment for ALL is both successful and inexpensive for ALL individuals. Genomics has been critical in increasing ALL treatment efficacy over the last 25 years and has the potential to fundamentally alter the character of ALL management (Perdana et al., 2020). Furthermore, genomics will focus more on drugs and testing that dictate each individual’s administration and sequence of therapies over the next decade

Changes in Approaches to Care when New Evidence Warrants Evaluation of other Options for Improving Outcomes or Decreasing Adverse Events

When children and adolescents with ALL are administered customized pediatric treatment regimens, they may have successful productivity. The introduction of new T-cell-based medication as a therapeutic approach for ALL highlights the importance of improving medical decisions for patients with recurrent B-cell lymphoma (Follini et al., 2019). T-cells are extracted from individuals with refractory B-cell ALL and genetically engineered with the 19-28z chimeric antigen-binding site design (Follini et al., 2019). The antigen binding site comprises a CD19-binding protein connected to the transduction elements of the CD28 costimulatory interface and the CD3 multifaceted ζ-chain. With this new approach to care, the treatment outcomes of ALL patients are improved.

Plan for Educating Colleagues and Patients on this Disorder

Individuals with ALL should be urged to seek medical assistance quickly if they develop a fever or show symptoms of bleeding. Additionally, patients with leukemia receiving treatment should avoid crowds and individuals with communicable diseases, particularly youngsters with infectious diseases. While individuals with ALL may engage in activities as permitted, they may be unable to engage in rigorous tasks such as weightlifting or exercising. Additionally, these persons should adopt a neutropenic regimen as follows: No raw fruits or vegetables are permitted; all foodstuffs must be prepared, and meat must be boiled to a well-done temperature.

References

American Cancer Society. (2018). Cancer.

Follini, E., Marchesini, M., & Roti, G. (2019). . International Journal of Molecular Sciences, 20(12), 3021.

Jiménez-Morales, S., Hidalgo-Miranda, A., & Ramírez-Bello, J. (2017). Boletín Médico Del Hospital Infantil de México (English Edition), 74(1), 13–26.

Miladinia, M., Baraz, S., Shariati, A., & Malehi, A. S. (2017). Effects of slow-stroke back massage on symptom cluster in adult patients with acute leukemia: supportive care in cancer nursing. Cancer Nursing, 40(1), 31-38. Web.

Perdana, A. B., Saputra, F., & Aisyi, M. (2020). . Indonesian Journal of Cancer, 14(4), 115-116.

Slayton, W. B., Schultz, K. R., Silverman, L. B., & Hunger, S. P. (2020). Pediatric Blood & Cancer, 67(10), e28543.

Terwilliger, T, & Abdul-Hay, M. (2017). . Blood Cancer Journal, 7(6), e577.

Wright Clayton, E., Evans, B. J., Hazel, J. W., & Rothstein, M. A. (2019). Journal of Law and the Biosciences, 6(1), 1–36.

More related papers Related Essay Examples
Cite This paper
You're welcome to use this sample in your assignment. Be sure to cite it correctly

Reference

IvyPanda. (2023, January 22). Acute Lymphoblastic Leukemia and Nutritional Influences. https://ivypanda.com/essays/acute-lymphoblastic-leukemia-and-nutritional-influences/

Work Cited

"Acute Lymphoblastic Leukemia and Nutritional Influences." IvyPanda, 22 Jan. 2023, ivypanda.com/essays/acute-lymphoblastic-leukemia-and-nutritional-influences/.

References

IvyPanda. (2023) 'Acute Lymphoblastic Leukemia and Nutritional Influences'. 22 January.

References

IvyPanda. 2023. "Acute Lymphoblastic Leukemia and Nutritional Influences." January 22, 2023. https://ivypanda.com/essays/acute-lymphoblastic-leukemia-and-nutritional-influences/.

1. IvyPanda. "Acute Lymphoblastic Leukemia and Nutritional Influences." January 22, 2023. https://ivypanda.com/essays/acute-lymphoblastic-leukemia-and-nutritional-influences/.


Bibliography


IvyPanda. "Acute Lymphoblastic Leukemia and Nutritional Influences." January 22, 2023. https://ivypanda.com/essays/acute-lymphoblastic-leukemia-and-nutritional-influences/.

If, for any reason, you believe that this content should not be published on our website, please request its removal.
Updated:
This academic paper example has been carefully picked, checked and refined by our editorial team.
No AI was involved: only quilified experts contributed.
You are free to use it for the following purposes:
  • To find inspiration for your paper and overcome writer’s block
  • As a source of information (ensure proper referencing)
  • As a template for you assignment
Privacy Settings

IvyPanda uses cookies and similar technologies to enhance your experience, enabling functionalities such as:

  • Basic site functions
  • Ensuring secure, safe transactions
  • Secure account login
  • Remembering account, browser, and regional preferences
  • Remembering privacy and security settings
  • Analyzing site traffic and usage
  • Personalized search, content, and recommendations
  • Displaying relevant, targeted ads on and off IvyPanda

Please refer to IvyPanda's Cookies Policy and Privacy Policy for detailed information.

Required Cookies & Technologies
Always active

Certain technologies we use are essential for critical functions such as security and site integrity, account authentication, security and privacy preferences, internal site usage and maintenance data, and ensuring the site operates correctly for browsing and transactions.

Site Customization

Cookies and similar technologies are used to enhance your experience by:

  • Remembering general and regional preferences
  • Personalizing content, search, recommendations, and offers

Some functions, such as personalized recommendations, account preferences, or localization, may not work correctly without these technologies. For more details, please refer to IvyPanda's Cookies Policy.

Personalized Advertising

To enable personalized advertising (such as interest-based ads), we may share your data with our marketing and advertising partners using cookies and other technologies. These partners may have their own information collected about you. Turning off the personalized advertising setting won't stop you from seeing IvyPanda ads, but it may make the ads you see less relevant or more repetitive.

Personalized advertising may be considered a "sale" or "sharing" of the information under California and other state privacy laws, and you may have the right to opt out. Turning off personalized advertising allows you to exercise your right to opt out. Learn more in IvyPanda's Cookies Policy and Privacy Policy.

1 / 1